Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial

Rory J. McCrimmon (Lead / Corresponding author), Philip Home, Alice Y. Y. Cheng, Francesco Giorgino, Vivian Fonseca, Elisabeth Souhami, Agustina Alvarez, Pascaline Picard, Julio Rosenstock

    Research output: Contribution to journalArticlepeer-review

    12 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences